Establishing cancer profiling to develop innovative personalized medicine and novel therapeutics

We pursued research and development of the characteristics of “cancer stem cells,” the core of pathologies, toward applicable levels by constructing a drug discovery/development platform that is unparalleled in the world on the basis of integrated cutting-edge complex knowledge. By distinguishing from the conventional linear progress expansion from basic to clinical research, we aim at the accumulation of multidimensionally networking information knowledge and application for development, demonstrating the most of academic flexibility. We aim to contribute to the industry by constructing highly accurate humanizing models, precisely reflecting patient pathologies, innovative cancer metabolism analysis of cancer stem cells, transomics analysis, highly accurate predictive molecular markers, companion drug development, next-generation nucleic acid drug development, innovative drug delivery systems, redevelopment of dropped drugs, data manning and science, machine leaning, and others.